{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:05:51Z","timestamp":1784556351477,"version":"3.55.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.13643","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T15:23:26Z","timestamp":1653405806000},"page":"e2213643","source":"Crossref","is-referenced-by-count":69,"title":["Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation"],"prefix":"10.1001","volume":"5","author":[{"given":"Tapio","family":"Paljarvi","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Oxford, Warneford Hospital, Headington, Oxford, England, United Kingdom"},{"name":"Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Forton","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital for Wales, Heath Park, Cardiff, Wales, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierra","family":"Luciano","sequence":"additional","affiliation":[{"name":"TriNetX, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo","family":"Herttua","sequence":"additional","affiliation":[{"name":"Department of Public Health, University of Southern Denmark, Esbjerg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seena","family":"Fazel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Oxford, Warneford Hospital, Headington, Oxford, England, United Kingdom"},{"name":"Oxford Health National Health Service Foundation Trust, Warneford Hospital, Oxford, England, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"issue":"4","key":"zoi220405r1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.rmed.2004.09.008","article-title":"Short-term effects of montelukast in stable patients with moderate to severe COPD.","volume":"99","author":"Celik","year":"2005","journal-title":"Respir Med"},{"key":"zoi220405r2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.sleep.2020.11.009","article-title":"The efficacy and safety of montelukast in children with obstructive sleep apnea: a systematic review and meta-analysis.","volume":"78","author":"Ji","year":"2021","journal-title":"Sleep Med"},{"issue":"11","key":"zoi220405r3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2174\/1874205X01711010007","article-title":"Case series using montelukast in patients with memory loss and dementia.","volume":"11","author":"Rozin","year":"2017","journal-title":"Open Neurol J"},{"issue":"7","key":"zoi220405r4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00228-017-2242-2","article-title":"The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.","volume":"73","author":"Hoxha","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"842","key":"zoi220405r5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejphar.2018.10.040","article-title":"A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer\u2019s disease.","volume":"842","author":"Rahman","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"13","key":"zoi220405r6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/JEP.S277720","article-title":"Montelukast: the new therapeutic option for the treatment of epilepsy.","volume":"13","author":"Tesfaye","year":"2021","journal-title":"J Exp Pharmacol"},{"issue":"3","key":"zoi220405r7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s40264-017-0607-1","article-title":"Neuropsychiatric events associated with leukotriene-modifying agents: a systematic review.","volume":"41","author":"Law","year":"2018","journal-title":"Drug Saf"},{"issue":"7","key":"zoi220405r8","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.jaip.2021.02.057","article-title":"A boxed warning for montelukast: the FDA perspective.","volume":"9","author":"Clarridge","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"zoi220405r10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jaci.2009.08.011","article-title":"Analysis of behavior-related adverse experiences in clinical trials of montelukast.","volume":"124","author":"Philip","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"zoi220405r11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1081-1206(10)62307-1","article-title":"Safety of antileukotriene agents in asthma management.","volume":"86","author":"Spector","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"zoi220405r12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.1365-2222.2001.00969.x","article-title":"Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years.","volume":"31","author":"Storms","year":"2001","journal-title":"Clin Exp Allergy"},{"issue":"11","key":"zoi220405r13","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1016\/j.rmed.2006.02.026","article-title":"Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.","volume":"100","author":"Virchow","year":"2006","journal-title":"Respir Med"},{"issue":"1","key":"zoi220405r14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/15563650.2017.1337123","article-title":"Adverse events are rare after single-dose montelukast exposures in children.","volume":"56","author":"Arnold","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"issue":"6","key":"zoi220405r15","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/ppul.21018","article-title":"Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.","volume":"44","author":"Bisgaard","year":"2009","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"zoi220405r16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2165\/11587260-000000000-00000","article-title":"Association between leukotriene-modifying agents and suicide: what is the evidence?","volume":"34","author":"Schumock","year":"2011","journal-title":"Drug Saf"},{"issue":"1-2","key":"zoi220405r17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000366164","article-title":"Montelukast-induced adverse drug reactions: a review of case reports in the literature.","volume":"94","author":"Calapai","year":"2014","journal-title":"Pharmacology"},{"issue":"4","key":"zoi220405r18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/pds.3758","article-title":"Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study.","volume":"24","author":"Ali","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"zoi220405r19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.psym.2017.08.005","article-title":"The association between leukotriene-modifying agents and suicidality: a review of literature.","volume":"59","author":"Khalid","year":"2018","journal-title":"Psychosomatics"},{"issue":"2","key":"zoi220405r20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00148-2017","article-title":"Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice.","volume":"50","author":"Benard","year":"2017","journal-title":"Eur Respir J"},{"issue":"5","key":"zoi220405r21","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.341","article-title":"Adverse drug reactions of montelukast in children and adults.","volume":"5","author":"Haarman","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"zoi220405r22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jpeds.2019.02.009","article-title":"Montelukast and neuropsychiatric events in children with asthma: a nested case-control study.","volume":"209","author":"Glockler-Lauf","year":"2019","journal-title":"J Pediatr"},{"issue":"6","key":"zoi220405r23","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1183\/09031936.00092812","article-title":"Nightmares induced by montelukast in children and adults.","volume":"40","author":"Cereza","year":"2012","journal-title":"Eur Respir J"},{"issue":"1","key":"zoi220405r24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jaip.2020.07.052","article-title":"Risk of psychiatric adverse events among montelukast users.","volume":"9","author":"Sansing-Foster","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"zoi220405r25","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3109\/02770903.2013.823445","article-title":"Antidepressant medication dispensing among montelukast initiators.","volume":"50","author":"Zhou","year":"2013","journal-title":"J Asthma"},{"issue":"12","key":"zoi220405r26","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/pds.v27.12","article-title":"Treatment with montelukast and antidepressive medication-a symmetry analysis.","volume":"27","author":"Winkel","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"zoi220405r27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3109\/02770903.2013.823447","article-title":"A review on leukotrienes and their receptors with reference to asthma.","volume":"50","author":"Singh","year":"2013","journal-title":"J Asthma"},{"issue":"11","key":"zoi220405r28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S2215-0366(20)30311-4","article-title":"Associations between statin use and suicidality, depression, anxiety, and seizures: a Swedish total-population cohort study.","volume":"7","author":"Molero","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"zoi220405r9","unstructured":"UK Medicines and Healthcare Products Regulatory Agency. Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions. Accessed August 2021. https:\/\/www.gov.uk\/drug-safety-update\/montelukast-singulair-reminder-of-the-risk-of-neuropsychiatric-reactions"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2792596\/paljarvi_2022_oi_220405_1652711394.11157.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T15:23:31Z","timestamp":1653405811000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2792596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.13643","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]}}}